|
Market Data
BMRN is currently trading at $54.64, giving BioMarin Pharmaceutical Inc. a market cap of 10.37B and a P/E ratio of 29.7. Today's range spans $54.08–$54.97, with shares opening at $54.51 and moving up $0.00 (0.0%) from the prior close. DailyIQ's technical score sits at 18/100 (SELL) with a news sentiment reading of 60/100.
Over the past year BMRN has traded between $50.76 and $66.28 - the current price is +7.6% off the 52-week low and -17.6% from the high.
Macro sensitivity explains some of BMRN's bearish setup (18/100, SELL) - at 10.37B in the broader market market cap, interest rate shifts, currency moves, or commodity price changes can create fundamental headwinds that compound the technical deterioration. Sentiment: bullish (60/100). Price: $54.64 (in the lower half of its 52-week range). The current P/E ratio stands at 29.7. Annual range: $50.76–$66.28. The question for investors is whether the macro driver is transient or structural - because the answer determines whether this is a tradeable dip or a deeper re-rating.
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q1'26 | $0.98 | - | - |
| Q1'25 | $0.95 | $1.13 | +18.6% |
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q1'26 | $754M | - | - |
| Q1'25 | - | $745M | - |
Sentiment gathered from recent headlines
Most recent articles, ranked by recency (click to expand).